FindTrial
Sign In

EFFECTS OF DURAL TUBE RELEASE IN ACUTE EPISODE OF PRIMARY HEADACHE ON INTENSITY, FREQUENCY AND IMPACT ON ADLs - A PROSPECTIVE PLACEBO CONTROLLED TRIAL

IMMEDIATE AND SHORT TERM EFFECTS OF DURAL TUBE RELEASE IN ACUTE EPISODE OF PRIMARY HEADACHE ON INTENSITY, FREQUENCY AND IMPACT ON ADLs - A PROSPECTIVE PLACEBO CLINICAL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045499
Enrollment
40
Registered
2022-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dural Tube Release: 5 times a week for 1 week. 3 sets of dural tube stretch for 30 seconds each self stretch, 3 sets of 30 seconds each Control Intervention1: placebo dural tube release

Sponsors

KAHER Institute of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals in 20 - 50 years of age. Individuals who experienced headache in the past 24 hours with intensity ranging from 3-7 on Numeric Pain Rating Scale. Individuals having primary type of headache namely migraine, tension-type headache, cluster and cervicogenic headaches. Clinically diagnosed migraine, tension type, cluster and cervicogenic headache by physiotherapists using ICHD-3.

Exclusion criteria

Exclusion criteria: Individuals with secondary type of headache namely, headaches associated with head trauma, substances or their withdrawal, hangover, fever headache, disorders of neck, eyes, ears, sinuses, cervical rib, pregnancy. History of hypertension, stroke, psychiatric disorders, balance issues, vertigo. Individuals with altered sensorium, hearing aids. Individuals taking pain medications for headache. Individuals having head injuries due to trauma, space occupying lesions

Design outcomes

Primary

MeasureTime frame
NUMERIC PAIN RATING SCALE (NPRS) HEADACHE DISABILITY INVENTORY HEADACHE IMPACT TEST (HIT-6)Timepoint: 1 month—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactSoumya Hulamani

KAHER INSTITUTE OF PHYSIOTHERAPY

aartiwelling@klekipt.edu.in9448814569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026